LifeStance Health Group (LFST) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.11
- Estimate
- $0.08
- Surprise
- +26.7%
- Revenue (period 2026-09-30)
- $455.9M
- Score today
- 5.7/10
Revenue source: xbrl.
How the report landed
LifeStance Health Group (LFST) beat the $0.08 estimate with adjusted EPS of $0.11 — a large 26.7% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates LFST Hold at 5.7/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +26.7% surprise compares with a +33.5% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Analyst target reached - limited upside remaining
- V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4)
- Target reached (-10.2% upside)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $13.99
- Stop
- $13.02
The stock trades at 74.6× trailing but 31.2× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 75 — a level conventionally read as overbought; gains at these levels often lean on momentum.
Model outputs from TrendMatrix’s engine as of 2026-11-06 — shown for context, not personalized investment advice.
LFST at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Care Facilities
- Market cap
- $5.11B
- P/E (fwd)
- 31.2
- P/E (ttm)
- 74.6
- 52-week range
- $5.10–$15.66
- Off 52-week high
- 10.6%
- RSI (14)
- 75
- Volume vs avg
- 0.45×
- Score today
- 5.7/10